Ocular adverse events associated with antibody-drug conjugates for cancer: evidence and management strategies.
Ocular adverse events associated with antibody-drug conjugates for cancer: evidence and management strategies. Oncologist. 2024 Nov 04; 29(11):e1435-e1451.